Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
08/2012
08/29/2012CN102652020A Combination preparations comprising exosomes and corticosteroid
08/29/2012CN102649787A (benzimidazole-2-yl)pyridine derivative and application thereof to preparation of anticoagulant medicines
08/29/2012CN102648953A External-use medicinal liquor used for treating rheumatoid bone disease
08/29/2012CN102648950A Traditional Chinese medicinal composition for eliminating body fatigue and movement disorder and relieving pains
08/29/2012CN102648946A Warm compression thermal therapy liquid and preparation method thereof
08/29/2012CN102648929A Chinese medicinal composition for treating osteoarthritis and preparation method thereof
08/29/2012CN102648927A Production technology of petasites lactone compound
08/29/2012CN102293768B Use of koumine in preparation of drug for treating rheumatoid arthritis
08/29/2012CN102284028B Medicine for treating rheumatoid arthritis
08/29/2012CN102218081B Manufacturing method of crocodile bone powder
08/29/2012CN102212109B Bone polypeptide compound separated from ossotide injection and application thereof
08/29/2012CN102178894B Plaster and preparation method of plaster
08/29/2012CN102133282B Medicament for treating femoral head necrosis
08/29/2012CN102133253B Application of affine cudweed extractive in preparing medicaments for preventing and curing chronic infectious arthritis
08/29/2012CN102093308B New crystal forms of Febuxostat and preparation methods thereof
08/29/2012CN102058579B Application of dehydrocostuslactone to preparing drug for inhibiting angiogenesis
08/29/2012CN102048925B TCM plaster used for coaptation
08/29/2012CN101961447B Novel preparation method, preparation and application of Chinese medicinal composition
08/29/2012CN101732413B Chinese medicinal composition for treating arthromyodynia and preparation method thereof
08/29/2012CN101574391B Prevention and treatment of diseases induced by microcirculation disturbance with compatible combination of total salvianolic acid and panax notoginoside
08/29/2012CN101497589B Method for synthesizing 2-(3-cyano-4- isobutoxy phenyl)-4-methyl-carboxylate
08/29/2012CN101433572B Herbal preparation for joints
08/29/2012CN101336972B Qingpeng paste and detection method thereof
08/29/2012CN101332166B Hemorrhoid cleaning moisture paper tissue and manufacture method thereof
08/29/2012CN101272767B Morphous solid dispersions of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide
08/29/2012CN101190267B Medicinal composition for treating cervical vertebra disease
08/29/2012CN101108878B Glp-1 analogues
08/29/2012CN101028519B Pharmaceutical composition for treating immune diseases
08/28/2012US8252838 Diclofenac topical formulation
08/28/2012US8252818 Nicotinamide derivatives useful as P38 inhibitors
08/28/2012US8252794 Composition for regenerative treatment of cartilage disease
08/28/2012US8252739 Albumin fusion proteins
08/28/2012CA2550441C Benzimidazole derivatives and medical uses thereof
08/28/2012CA2533846C Means and methods for treating a disease which is associated with an excess transport of hyaluronan across a lipid bilayer
08/28/2012CA2497353C Method for preventing or reducing secondary fractures after hip fracture
08/28/2012CA2476939C Pharmaceutical combinations of cox-2 inhibitors and opiates
08/28/2012CA2409930C Use of zoledronate for the manufacture of a medicament for the treatment of bone metabolism diseases
08/28/2012CA2387805C Nucleic acids encoding endotheliases, endotheliases and uses thereof
08/23/2012WO2012112919A1 Stromal derived factor inhibition and cxcr4 blockade
08/23/2012WO2012112723A2 Thin shell graft for cartilage resurfacing
08/23/2012WO2012111852A1 Therapeutic agent for vertebral body fracture and method for evaluating same
08/23/2012WO2012111795A1 Ameliorating agent for lifestyle-related diseases containing water extract of colored onion
08/23/2012WO2012111643A1 Adiponectin production promoter, and medicinal composition, food, drink and feed containing adiponectin production promoter
08/23/2012WO2012110946A1 Pharmaceutical composition comprising the pde4 enzyme inhibitor revamilast and a disease modifying agent, preferably methotrexate
08/23/2012WO2012110674A1 Use of a vegetable extract as an active principle in the production of a pharmacologically active product for the treatment of tissue lesions, and method for obtaining said extract
08/23/2012WO2012110636A2 Carrier peptides for cell delivery
08/23/2012WO2012110017A1 Dietetic or pharmaceutical preparation containing tartary buckwheat
08/23/2012WO2012109975A1 Pegylated analogue protein of canine urate oxidase, preparation method and use thereof
08/23/2012WO2012090006A3 Methods for improving fracture healing and bone formation
08/23/2012WO2012082014A3 Pharmaceutical composition for stimulating the regeneration of supporting tissues
08/23/2012WO2012072692A3 Use of cytokine-releasing, biodegradable particles in hyaluronic acid for the treatment of cartilage defects, in particular of osteoarthrosis
08/23/2012WO2011061561A3 Method of obtaining regenerative molecular matrices and regenerative molecular matrices thus obtained
08/23/2012US20120214869 Novel ligand activators of the rar receptors and pharmaceutical/cosmetic applications thereof
08/23/2012US20120214866 Treatment with cytokines
08/23/2012US20120214858 Imidamide sphingosine kinase inhibitors
08/23/2012US20120214854 Carboxy oxazole or thiazole compounds as dgat- 1 inhibitors useful for the treatment of obesity
08/23/2012US20120214850 Compounds for treatment of cell proliferative diseases
08/23/2012US20120214847 2-[1-PHENYL-5-HYDROXY-4a-SUBSTITUTED-HEXAHYDROCYCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
08/23/2012US20120214846 Hexahydrocyclopentyl[f]indazole pyridyl ethanols and derivatives thereof as selective glucocorticoid receptor modulators
08/23/2012US20120214841 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
08/23/2012US20120214840 Indolizine inhibitors of 5-lipoxygenase
08/23/2012US20120214814 Antioxidant inflammation modulators: oleanolic acid derivatives with amino acid and other modifications at c-17
08/23/2012US20120214807 Compounds useful as antagonists of ccr2
08/23/2012US20120214806 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazines
08/23/2012US20120214804 Pharmaceutical composition comprising indole compound
08/23/2012US20120214801 Compositions and methods relating to novel compounds and targets thereof
08/23/2012US20120214800 Organic Compounds
08/23/2012US20120214794 Heteroaryls and uses thereof
08/23/2012US20120214792 Thieno- adn furo-pyrimidine modulators of the histamine h4 receptor
08/23/2012US20120214766 Cannabinoid receptor modulators
08/23/2012US20120214762 6,5-heterocyclic propargylic alcohol compounds and uses therefor
08/23/2012US20120214754 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof
08/23/2012US20120214741 Vdac1 compositions and methods of use thereof for regulating apoptosis
08/23/2012US20120214740 Medicinal Compositions Containing Highly Functionalized Chimeric Protein
08/23/2012US20120214739 Fgf variants and methods for use thereof
08/23/2012US20120214738 Therapeutic agent and therapeutic method for periodontal diseases and pulpal diseases
08/23/2012US20120214733 Oxytocin receptor agonists
08/23/2012US20120214731 Compound ws 727713
08/23/2012US20120214729 Composition for preventing or treating inflammation
08/23/2012US20120213872 Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
08/23/2012US20120213859 Process for demineralization of bone matrix with preservation of natural growth factors
08/23/2012US20120213855 Dosage forms for weakly ionizable compounds
08/23/2012US20120213842 Methods of making and using compositions comprising flavonoids
08/23/2012US20120213837 Compositions and methods for bioactive coatings to improve allograft incorporation
08/23/2012US20120213833 Prevotella histicola preparations and the treatment of autoimmune conditions
08/23/2012US20120213831 Microspheres for active embolization
08/23/2012US20120213826 Use of Pro-Inflammatory Compounds for Promoting Bone Formation
08/23/2012US20120213823 Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
08/23/2012US20120213799 Compositions and methods for treating inflammatory disorders
08/23/2012US20120213792 Human antibodies that bind human il-12 and methods for producing
08/23/2012US20120213777 Vascular endothelial growth factor 2
08/23/2012US20120213776 Antibodies to granulocyte-macrophage colony-stimulating factor
08/23/2012US20120213774 Antibodies against human IL33R and uses thereof
08/23/2012US20120213773 Binding domain-immunoglobulin fusion proteins
08/23/2012US20120213768 Diagnostic and Therapeutic Uses for B Cell Maturation Antigen
08/23/2012US20120213758 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
08/23/2012US20120213752 Isolated stromal cells and methods of using the same
08/23/2012US20120213745 Serum-free media and their uses for chondrocyte expansion
08/23/2012US20120213731 Methods and compositions for treating autoimmune diseases
08/23/2012US20120213702 Novel diagnostic agents for the non-invasive in vivo imaging of aminopeptidase n (apn/cd13)
1 ... 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 ... 820